These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17704407)

  • 1. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.
    Cussenot O; Azzouzi AR; Nicolaiew N; Fromont G; Mangin P; Cormier L; Fournier G; Valeri A; Larre S; Thibault F; Giordanella JP; Pouchard M; Zheng Y; Hamdy FC; Cox A; Cancel-Tassin G
    J Clin Oncol; 2007 Aug; 25(24):3596-602. PubMed ID: 17704407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
    Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
    Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes.
    Berstein L; Zimarina T; Imyanitov E; Kovalevskij A; Maximov S; Pujol P; Thijssen J
    Maturitas; 2006 Jul; 54(4):352-5. PubMed ID: 16730930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
    Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H
    Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry.
    Brureau L; Moningo D; Emeville E; Ferdinand S; Punga A; Lufuma S; Blanchet P; Romana M; Multigner L
    PLoS One; 2016; 11(4):e0153609. PubMed ID: 27074016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk.
    Nock NL; Cicek MS; Li L; Liu X; Rybicki BA; Moreira A; Plummer SJ; Casey G; Witte JS
    Carcinogenesis; 2006 Sep; 27(9):1842-8. PubMed ID: 16569655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
    Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
    Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system].
    Berstein LM; Zimarina TS; Tsyrlina EV; Kovalevskiĭ AIu; Imianitov EN
    Vopr Onkol; 2004; 50(2):169-73. PubMed ID: 15176218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
    Saintot M; Malaveille C; Hautefeuille A; Gerber M
    Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients.
    Kachakova D; Mitkova A; Popov E; Beltcheva O; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R
    Turk J Med Sci; 2016 Apr; 46(3):626-40. PubMed ID: 27513235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
    McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
    Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.
    Latil AG; Azzouzi R; Cancel GS; Guillaume EC; Cochan-Priollet B; Berthon PL; Cussenot O
    Cancer; 2001 Sep; 92(5):1130-7. PubMed ID: 11571725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
    Miyoshi Y; Noguchi S
    Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
    Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk.
    Ahsan H; Chen Y; Whittemore AS; Kibriya MG; Gurvich I; Senie RT; Santella RM
    Breast Cancer Res Treat; 2004 May; 85(2):121-31. PubMed ID: 15111770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness.
    Cicek MS; Liu X; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2173-7. PubMed ID: 16172228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients.
    Yang SY; Yang TY; Chen KC; Li YJ; Hsu KH; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Shen CY; Chang GC; Yang PC; Chen CJ
    Clin Cancer Res; 2011 Apr; 17(8):2149-58. PubMed ID: 21300759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.